Saturday 7 November 2026
Export MDXG’s income statement to Excel — free account
MiMedx Group, Inc
MDXG Healthcare Biotechnology
MiMedx Group, Inc’s revenue for fiscal 2025 (year ended December 2025) was $418.6 million, up 20.0% from fiscal 2024.
- Revenue
- −45.2%
- EPS
- −154.1%
- Free cash flow
- −87.2%
- Total debt
- −6.80%
Quarter to September 2026, against a year earlier
3.31
0.03
+0.91%
Follow MDXG
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 5 | 5 | 4 |
| 21.61% | 13.77% | 2.88% | (8.53%) | ||
| 16.02% | 10.60% | 2.18% | (6.58%) | ||
ROIC |
36.84% | 24.56% | 5.62% | (17.40%) | |
Return on Tangible Assets |
22.29% | 15.31% | 3.63% | (12.89%) | |
Average Days of Receivables |
66.01 | 43.15 | 42.44 | 44.79 | |
Free Cash Flow per Share |
0.49 | 0.47 | 0.30 | 0.13 | |
Free Cash Flow |
72.97 | 69.31 | 44.43 | 19.02 | |
Capital Expenditures |
(1.03) | (1.27) | (1.72) | (1.72) | |
| Other line items | |||||
Cash ROIC |
16.56% | 16.49% | 12.04% | 5.73% | |
Accounts Receivable Turnover |
6.37 | 7.19 | 6.43 | 5.26 | |
Accounts Payable Turnover |
6.66 | 7.26 | 8.95 | 5.94 | |
Inventory Turnover |
2.97 | 2.94 | 3.28 | 2.84 | |
Average Days of Payables |
72.63 | 56.68 | 40.29 | 62.58 | |
Days of Inventory on Hand |
126.68 | 129.68 | 101.70 | 116.87 | |
Tax Rate |
(0.27) | (0.27) | (0.46) | (0.14) | |
Research and Development Expense of Revenue |
3.61% | 4.09% | 4.33% | 4.77% | |
Selling, General and Administrative Expense of Revenue |
63.59% | 66.63% | 71.82% | 80.46% | |
Share Based Compensation of Revenue |
3.92% | 2.68% | 1.86% | 1.61% | |
Operating CF/Net income |
1.52 | 2.30 | 7.40 | (1.08) | |
Depreciation/Fixed assets |
3.16 | 2.80 | 2.37 | 1.66 | |
Capex/Depreciation |
(0.07) | (0.10) | (0.15) | (0.22) | |
Revenue per Share |
2.83 | 2.62 | 2.40 | 2.08 | |
Operating CF per Share |
0.50 | 0.48 | 0.31 | 0.14 | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026